Mysore Turmeric (Curcuma longa)

Mysore Turmeric (Curcuma longa) is a high-yielding Indian cultivar prized primarily for its elevated curcumin content, which can reach up to 5.02% in related Indian varieties. Curcumin, the principal polyphenolic bioactive, inhibits NF-κB signaling and modulates inflammatory cytokines, though no clinical trials have been conducted specifically on the Mysore cultivar.

Origin & History

Mysore Turmeric is a cultivar variant of Curcuma longa L., a perennial herbaceous plant primarily cultivated in regions like Mysore, Karnataka, India. The rhizomes are harvested after 7-9 months, boiled, cured, and dried, with curing recovery rates of 19-25% and yields reaching up to 33.67 t/ha in field trials.

Historical & Cultural Context

Mysore Turmeric has historical context in Indian traditional agriculture for spice production in districts like Mysore and Chamarajnagar for centuries. It is valued for its curcumin-derived color and flavor as a staple rhizomatous crop in tropical India, though no specific traditional medicine system applications are documented in the available research.

Health Benefits

• No clinical health benefits documented - research focuses exclusively on agricultural yield trials
• Deep yellow color attributed to curcumin content (up to 5.02% in related Indian varieties) - no clinical evidence provided
• Traditional spice use in Indian cuisine for color and flavor - no therapeutic studies available
• Agricultural trials show high rhizome yields but no health outcome data
• No human studies, RCTs, or meta-analyses exist for this specific cultivar

How It Works

Curcumin, the primary bioactive polyphenol in Curcuma longa including the Mysore cultivar, suppresses NF-κB transcription factor activation, thereby reducing downstream expression of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. Curcumin also inhibits COX-2 and LOX enzymes involved in eicosanoid synthesis, and modulates the Nrf2-Keap1 antioxidant pathway to upregulate heme oxygenase-1 (HO-1). Additionally, curcumin chelates reactive oxygen species and inhibits phospholipase A2, contributing to its broad anti-inflammatory and antioxidant pharmacological profile documented in general Curcuma longa research.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specific to Mysore Turmeric were found in the research. All available studies focus exclusively on agronomic field trials examining yield, growth, and cultivation quality in Karnataka, using randomized complete block design (RCBD) with 16-19 cultivars and n=3 replications per trial.

Clinical Summary

No clinical trials have been conducted specifically on the Mysore Turmeric cultivar; available research is limited to agricultural yield and agronomic performance studies in Indian growing regions. General curcumin research across Curcuma longa varieties includes randomized controlled trials in osteoarthritis, metabolic syndrome, and inflammatory bowel conditions, typically using 500–2000 mg/day of curcumin extract with sample sizes of 30–120 participants. A 2016 meta-analysis of 8 RCTs found curcumin supplementation significantly reduced CRP and IL-6 in inflammatory conditions, but these findings cannot be extrapolated exclusively to the Mysore cultivar without cultivar-specific bioavailability and phytochemical profiling data. Evidence strength for Mysore Turmeric specifically remains very low due to a complete absence of human interventional studies.

Nutritional Profile

Mysore Turmeric (Curcuma longa) shares the general nutritional composition of dried turmeric powder. Per 100g dried powder: Carbohydrates ~65g (including dietary fiber ~13g), Protein ~8g, Fat ~10g (primarily unsaturated fatty acids including linolenic and oleic acid), Moisture ~8-10g. Key micronutrients include Iron (~41mg/100g), Potassium (~2500mg/100g), Magnesium (~193mg/100g), Calcium (~168mg/100g), Phosphorus (~268mg/100g), Zinc (~4.4mg/100g), and Manganese (~7.8mg/100g). Vitamins present include Vitamin C (~25mg/100g), Vitamin B6 (~1.8mg/100g), Niacin (~5.1mg/100g), and Vitamin E (~3.1mg/100g). The defining bioactive compound is curcumin (a polyphenolic curcuminoid), with Mysore-type Indian varieties documented at up to 5.02% curcumin content by dry weight — notably higher than many commercial varieties averaging 2-3%. Additional curcuminoids include demethoxycurcumin and bisdemethoxycurcumin at lower concentrations (~0.5-1.0% combined). Essential oils constitute approximately 3-7% of dry weight, including turmerone, ar-turmerone, and zingiberene. Bioavailability note: Curcumin has inherently poor oral bioavailability (~1%) due to rapid metabolism and low water solubility; co-consumption with piperine (black pepper) or fat-based foods significantly enhances absorption. Oxalate content is moderate (~489mg/100g), relevant for individuals with kidney stone risk.

Preparation & Dosage

No clinically studied dosage ranges are available for Mysore Turmeric, as research lacks human trials and focuses solely on agricultural yields. Cultivation studies reference farm-level inputs (FYM 25 t/ha and NPK 150:125:250 kg/ha) but provide no standardization data for curcumin content or therapeutic dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients documented in available research

Safety & Interactions

Curcumin from Curcuma longa at doses up to 8 g/day has demonstrated an acceptable safety profile in phase I trials, with gastrointestinal discomfort, nausea, and diarrhea reported at higher doses. Curcumin inhibits CYP3A4, CYP1A2, and P-glycoprotein, potentially elevating plasma concentrations of drugs including warfarin, tacrolimus, and certain statins, requiring caution in polypharmacy settings. Its antiplatelet activity may amplify bleeding risk when combined with NSAIDs, aspirin, or anticoagulants, and it should be used cautiously in patients with gallbladder disease due to choleretic effects. Pregnancy safety has not been established for supplemental curcumin doses beyond typical culinary use, and high-dose supplementation is generally discouraged during pregnancy and lactation.